NEW YORK (GenomeWeb News) – Affymetrix's eBioscience business has sold its TrueBlot IP/Western blot product line to Rockland Immunochemicals for an undisclosed price.

The TrueBlot reagents are used in cancer, cell signaling, infectious disease, and other life sciences research to generate data in immunoprecipitation and Western blot experiments. Western blotting is performed to determine expression and quantitate target proteins in biological samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

The New York Times editorial board weighs in on scientific research misconduct.